Does CoolSculpting Work? Results and Reviews

CoolSculpting is a brand name for cryolipolysis — fat freezing — and the clearance defines what "working" can mean here.

The most recent clearance on file is K233732, dated September 12, 2024, for the CoolSculpting Elite system: an FDA-cleared Class II device, not an FDA-approved one.

Under that clearance, Elite is cleared for cold-assisted lipolysis of the upper arm, bra fat, back fat, banana roll (under the buttocks), thigh, abdomen and flank in people with a BMI of 30 or less.

Every figure below describes the fat layer in a bulge like those — not body weight.

The key evidence here is a 2015 systematic review of 19 cryolipolysis studies (Ingargiola et al., Plastic and Reconstructive Surgery).

It found average fat-layer reductions of 14.67% to 28.5% when measured with calipers and 10.3% to 25.5% when measured with ultrasound, no significant effect on blood lipids or liver tests, and mainly mild, short-term side effects.

These are averages across 19 studies — a study average is not a promise for any one person.

ASPS's description of the process puts a headline number on it: the injured fat cells are gradually eliminated by the body over four to six months, the fatty bulge decreases during that time, and the average fat reduction is about 20 percent of the treated bulge.

The maker's figure needs the most context.

Allergan's marketing cites up to 20–25% fat-layer reduction — a claim that traces to a clinical study of 10 people, in which that reduction was seen at 2 and 6 months in 6 of them.

It is a manufacturer claim from a very small study, not an expected average.

Start with the limits written into the clearance, because the documented results sit inside them.

The body areas above are cleared for people with a BMI of 30 or less.

The under-chin (submental) and under-jawline (submandibular) areas carry their own cleared limit: people with a BMI up to 46.2 — and for the under-chin area, the clearance also names affecting the appearance of lax tissue.

A person or an area outside those limits is outside the cleared use.

ASPS adds who may not see the change they want: people with loose skin or poor tone may not be suitable candidates.

ASPS also says people with cold-related conditions — cryoglobulinemia, cold urticaria and paroxysmal cold hemoglobinuria — should not have cryolipolysis, and that people who are pregnant or breastfeeding should not have nonsurgical fat reduction.

Allergan's safety information adds practical screening: patients should tell their doctor about pregnancy, recent surgery, a pre-existing hernia, or known sensitivities or allergies before treatment.

Even inside the limits, hold the expectations where ASPS holds them: its risk list for cryolipolysis includes surface irregularities, asymmetry and not getting the hoped-for result.

The averages above describe studies — they are not a prediction for the person reading this page, which is what a consultation with a licensed provider is for.

No — and the maker states it plainly.

Allergan's consumer safety information says CoolSculpting and CoolSculpting Elite are not treatments for weight loss.

The cleared use is the visible fat bulge in the named areas, within the BMI limits — not a number on the scale, and not a treatment for obesity.

The 2015 review stays inside that scope.

Its studies measured the treated fat layer with calipers or ultrasound, not pounds lost, and the review also measured blood lipids and liver tests and found no significant effect.

Weight reduction is a different treatment category; if that is the goal, that conversation belongs with a licensed provider, and our weight loss guide starts there.

That distinction is also the honest answer to "will CoolSculpting work for me?" For a visible fat bulge inside the cleared areas, the published evidence shows a measurable average reduction.

As a weight-loss treatment, the maker itself declines the claim.

Review sites and Reddit threads are where this question gets argued, and this page does not quote them.

No review-site rating or satisfaction survey for CoolSculpting appears among the sources behind this page — an FDA clearance, Allergan's safety information, ASPS and AAD guidance, and peer-reviewed studies — so we cannot check how any star rating was collected.

What the checkable record gives you is three places where a review's story and a measured result can diverge:

• Timing. For non-invasive fat-reduction devices, the AAD says results start as early as 3 weeks and most people see the full effect 3 to 6 months after the last treatment, and ASPS describes the injured fat cells clearing over four to six months. An account written the week after a session describes the appointment, not the outcome.
• The goal. A review judged in pounds was never testing the cleared use: Allergan's own safety information says CoolSculpting is not a weight-loss treatment.
• The result itself. ASPS lists not getting the hoped-for result among the risks of cryolipolysis, next to surface irregularities and asymmetry — a disappointed outcome is one the professional body treats as possible.

So use reviews for what they can show — how a practice communicates, quotes and handles problems — and use the measured record above to judge the treatment itself.

Reviews cannot settle efficacy; a consultation can at least establish the checkable facts — the device, the clearance, the limits and the plan.

Make these the questions before you book:

Then read the treatment end to end: our CoolSculpting guide covers how a session works, the full side-effect list including PAH, costs and the alternatives.